You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KYMR Sale Disclosure
Adams Brian · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$139.7K
Adams Brian Chief Legal Officer
KYMR
Kymera Therapeutics
KYMR
Transaction date
Sep 4, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed same day
KYMR daily price context
Close on/before transaction
$117.39
Sep 4, 2026
First close after public filing
$116.47
Sep 8, 2026
30-day return after filing
-5.68%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,209 shares @ $115.55
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-383874
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$744.3K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kymera Therapeutics, Inc. KYMR | Sale | Sep 4, 2026 | $251.25K |
| Kymera Therapeutics, Inc. KYMR Current | Sale | Sep 4, 2026 | $139.7K |
| Kymera Therapeutics, Inc. KYMR | Sale | Sep 4, 2026 | $353.35K |